An interventional study of Accelerometer and Step goal in Physical Activity, sponsored by Brandeis University. Completed at 1 site in United States. Open to participants aged 40 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-02-17.
Sponsored by Brandeis University · Not applicable, Interventional, and Supportive care
Among 2,858 studies in Motor Activity with a site in United States — 423 open to participants now, 564 under way, 9 of them phase 3. Motor Activity · United States.
Among the 2,858 studies in Motor Activity with a site in United States, this one is the 655th largest by enrollment of the 2,605 interventional ones that give a count, is one of 170 that started in 2018, is one of 2,243 with no phase, and was the 1,298th registered.
9,798 studies on the registry are indexed under Motor Activity; 1,910 are open to participants now.
Browse Motor Activity studies →423 of the 2,858 studies in Motor Activity with a site in United States are open now. Recruiting first, the newest first:
University of Miami · Sites in United States
University of Pennsylvania · Sites in United States
San Diego State University · Sites in United States
Beth Israel Deaconess Medical Center · Sites in United States
University of Arizona · Sites in United States
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 1,201 Motor Activity studies recruiting now, 517 (43%) set no upper age limit and 535 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.
This study: 40 Years to 65 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
2,858 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 139 · Phase 2 180 · Phase 3 83 · Phase 4 33
First in 1977; this study’s year is marked. 170 started in 2018.
This study's enrollment of 149 is above the median of 60 across 8,388 interventional studies indexed under Motor Activity.
Median enrollment 55 across the 2,605 interventional studies, 67 across the 240 observational. Of the 2,100 that completed or were terminated, 539 (26%) have results posted.
This tab as a report to print or save as PDF → With an account.
82 of 2,858 have an industry lead sponsor. The 10 most frequent:
Brandeis University is the lead sponsor of 13 studies on the registry; 2 are open to participants now.
Brandeis University has 5 studies filed under Motor Activity — fewer than ten, so there is no comparison to draw.
210 of the studies in Motor Activity with a site in United States that are under way reach primary completion within a year, 3 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07298915Phase 3University of VirginiaThe Effect of Exercise and Tirzepatide on Weight and Health Outcomes (EXER-MED) | 2026-12 |
| NCT06159335Phase 3University of Wisconsin, Madison18F-FLUC PET/MR in Patients With Brain Mets | 2027-06 |
| NCT05422534Phase 3Vanderbilt University Medical CenterCoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease | 2027-06-20 |
| NCT07125027National University of Natural MedicineA Multicomponent Intervention for Patients With Lumbosacral Radiculopathy: Move-MORE | 2026-11 |
| NCT06290713University of FloridaVasodilator and Exercise Study for DMD (VASO-REx) | 2026-11 |
Among the 2,858 studies in Motor Activity with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
While people commonly understand that regular physical exercise conveys many health benefits, only 20% of U.S. adults take regular exercise and they have difficulty maintaining new healthy behaviors. The goal of this study is to use a planning intervention to help establish and maintain a daily step regimen in working midlife adults. The investigators will ask participants to plan when, where, and how to act on a daily walking goal in conjunction with a scheduling intervention to increase the chances that they will maintain this new regimen. The effectiveness of three different scheduling interventions will be compared.
While people commonly understand that regular physical exercise conveys many health benefits, only 20% of U.S. adults take regular exercise and they have difficulty maintaining new healthy behaviors. The goal of this study is to use a planning intervention to help establish and maintain a daily step regimen in working midlife adults. The investigators will ask participants to plan when, where, and how to act on a daily walking goal in conjunction with a scheduling intervention to increase the chances that they will maintain this new regimen. Participants will be randomly assigned to one of three conditions: consistent schedule, inconsistent schedule, no schedule. All participants will be provided with an accelerometer to measure their daily activity and as a behavioral support for our intervention and they will be given a step goal. The goal given to each individual will be to increase immediately their daily steps to a level based on recommended guidelines (e.g., Hill, Wyatt, Reed, and Peters, 2003). The investigators will test which version of the scheduling intervention is most successful for increasing and maintaining step counts. It is predicted that participants in the consistent schedule condition will increase their step count more than those participants in the no schedule control condition, and that they will maintain this activity for a longer period after the intervention period is complete than those participants in the inconsistent schedule condition.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
This group will receive an accelerometer and daily step goal. They will monitor their steps over the 9 week duration of the study. They will also monitor their steps over the 9 week duration of the study. They will have the same level of contact as the other two conditions.
Device: Accelerometer · Behavioral: Step goal
This group will receive an accelerometer and daily step goal. They will monitor their steps over the 9 week duration of the study. They will have the same level of contact as the other two conditions. In addition they will plan when, where, and how they will take steps in consistent contexts, i.e., that are very similar from day to day.
Device: Accelerometer · Behavioral: Step goal · Behavioral: Consistent contexts
This group will receive an accelerometer and daily step goal. They will monitor their steps over the 9 week duration of the study. They will have the same level of contact as the other two conditions. In addition they will plan when, where, and how they will take steps in inconsistent contexts, i.e., that vary from day to day.
Device: Accelerometer · Behavioral: Step goal · Behavioral: Inconsistent contexts
Participants use an accelerometer to monitor their steps activity
Participants are given a daily step goal to aim for
Participants plan to take steps in contexts that are similar from day to day
Participants plan to take steps in contexts that vary from day to day
Physical activity
Number of steps taken each day as measured on accelerometer
Time frame: Daily for 9 weeks
Measures of well being
Feelings of satisfaction with life, perceived stress, mood and sleep quality
Time frame: Before and after intervention (5 weeks apart), and at followup (4 weeks later)
Physical activity self-efficacy and ease
Perceived ability and ease of being physically active
Time frame: Weekly for 4 weeks
Plan to share: No
Ran from Apr 2018 to primary completion in Jul 2019, 15 months.
Of 5,147 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's 15 months is below that.
Counting every sponsor, half of 5,207 studies reached it within 17 months; a quarter within 7 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Brandeis University